Aimovig and Fenofibrate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aimovig (erenumab-aooe) and Fenofibrate (fenofibrate). Common drug interactions include nausea among females and diabetes mellitus among males.

The phase IV clinical study analyzes what interactions people have when they take Aimovig and Fenofibrate. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Aimovig?

Aimovig has active ingredients of erenumab-aooe. eHealthMe is studying from 49,930 Aimovig users. Check the latest studies of Aimovig.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,456 Fenofibrate users. Check the latest studies of Fenofibrate.

On Jul, 21, 2026

38 people who take Aimovig and Fenofibrate together, and have interactions are studied.

Aimovig and Fenofibrate drug interactions.

What are the common drug interactions of Aimovig and Fenofibrate, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Migraine (headache)
Infusion site pain
Malaise (a feeling of general discomfort or uneasiness)
Urinary tract infection
Abdominal discomfort
Bone pain
Diarrhoea
Drug ineffective
Headache (pain in head)

male:

Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Defaecation urgency (a sudden compelling urge to defecate)
Fungal oesophagitis (fungal inflammation of the oesophagus)
Hospitalisation
Lung carcinoma cell type unspecified stage iv (the lung cancer has spread to other organs of the body, such as the other lung, brain, or liver)
Male orgasmic disorder (male sex satisfaction disease)
Micturition urgency (urgency to pass the urine)
Migraine (headache)
Nausea (feeling of having an urge to vomit)
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)

What are the common drug interactions of Aimovig and Fenofibrate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Feeling hot
Influenza like illness
Migraine (headache)
Nausea (feeling of having an urge to vomit)
Pain
Somnolence (a state of near-sleep, a strong desire for sleep)
Asthenia (weakness)
Constipation
Disability
Fatigue (feeling of tiredness)

40-49:

Bone pain
Drug ineffective
Headache (pain in head)
Increased appetite
Injection site bruising
Injection site pain
Limb discomfort (discomfort in leg)
Malaise (a feeling of general discomfort or uneasiness)
Weight increased
Infection

50-59:

Diarrhoea
Serum sickness (hypersensitivity reaction that results from the injection of heterologous or foreign protein or serum)
Visual impairment
Abdominal discomfort
Abdominal pain
Hyperthyroidism (over activity of the thyroid gland)
Hypokalaemia (low potassium)
Lip dry
Oral discomfort (pain or irritation in mouth)
Asthenia (weakness)

60+:

Nausea (feeling of having an urge to vomit)
Cystitis (inflammation of the wall of the bladder)
Infusion site pruritus (severe itching at infusion site)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Infusion site extravasation (flow of (blood or lymph) from infusion site)
Infusion site haemorrhage (bleeding from infusion site)
Injection site haemorrhage (bleeding from injection site)
Localised infection (infection at the single location)
Arrhythmia (irregular heartbeat)
Defaecation urgency (a sudden compelling urge to defecate)

What are the existing conditions these people have? *

Migraine (headache): 13 people, 34.21%
Immunodeficiency Common Variable: 7 people, 18.42%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 5.26%
Infection: 2 people, 5.26%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 2 people, 5.26%
Headache (pain in head): 2 people, 5.26%
Diabetes: 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Aimovig and Fenofibrate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously